Eli Lilly & Co earnings were $11.1B for the trailing 12 months ending Mar 31, 2025, with 80.9% growth year over year. The latest LLY earnings report on Mar 31, 2025 announced Q1 2025 earnings of $2.8B, down 37.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LLY reported annual earnings of $10.6B, with 102.1% growth. The next LLY earnings date is Aug 7, 2025.
LLY past earnings growth
How has LLY's earnings growth performed historically?
On LLY's earnings call on Invalid Date, Eli Lilly & Co (NYSE: LLY) reported Q1 2025 earnings per share (EPS) of $3.07, up 23.29% year over year. Total LLY earnings for the quarter were $2.76 billion. In the same quarter last year, Eli Lilly & Co's earnings per share (EPS) was $2.49.
The next LLY earnings call is Invalid Date. Add LLY to your watchlist to be reminded of Eli Lilly & Co's next earnings date.
Is Eli Lilly & Co profitable or losing money?
As of the last Eli Lilly & Co earnings report, Eli Lilly & Co is currently profitable. Eli Lilly & Co's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $11.11 billion, a 80.93% increase year over year.
What was LLY's earnings growth in the past year?
As of Eli Lilly & Co's earnings date in Invalid Date, Eli Lilly & Co's earnings has grown 80.94% year over year. This is 33.56 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 114.49%. LLY earnings in the past year totalled $11.11 billion.
What are Eli Lilly & Co's earnings expectations?
The current EPS estimate for Eli Lilly & Co's earnings report in Invalid Date is $5.57.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.